• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Vaccine . City-wide school-located influenza vaccination: A retrospective cohort study

tetano

Editor, Senior Moderator
Vaccine


. 2021 Sep 14;S0264-410X(21)01161-0.
doi: 10.1016/j.vaccine.2021.08.099. Online ahead of print.
City-wide school-located influenza vaccination: A retrospective cohort study


Jade Benjamin-Chung[SUP] 1 [/SUP], Benjamin F Arnold[SUP] 2 [/SUP], Kunal Mishra[SUP] 3 [/SUP], Chris J Kennedy[SUP] 3 [/SUP], Anna Nguyen[SUP] 3 [/SUP], Nolan N Pokpongkiat[SUP] 3 [/SUP], Stephanie Djajadi[SUP] 3 [/SUP], Anmol Seth[SUP] 3 [/SUP], Nicola P Klein[SUP] 4 [/SUP], Alan E Hubbard[SUP] 3 [/SUP], Arthur Reingold[SUP] 3 [/SUP], John M Colford Jr[SUP] 3 [/SUP]



Affiliations
Free article

Abstract

Background: We measured the effectiveness of a city-wide school-located influenza vaccination (SLIV) program implemented in over 102 elementary schools in Oakland, California.
Methods: We conducted a retrospective cohort study among Kaiser Permanente Northern California (KPNC) members of all ages residing in either the intervention or a multivariate-matched comparison site from September 2011 - August 2017. Outcomes included medically attended acute respiratory illness (MAARI), influenza hospitalization, and Oseltamivir prescriptions. We estimated difference-in-differences (DIDs) in 2014-15, 2015-16, and 2016-17 using generalized linear models and adjusted for race, ethnicity, age, sex, health plan, and language.
Results: Pre-intervention member characteristics were similar between sites. The proportion of KPNC members vaccinated for influenza by KPNC or the SLIV program was 8-11% higher in the intervention site than the comparison site during the intervention period. Among school-aged children, SLIV was associated with lower Oseltamivir prescriptions per 1,000 (DIDs: -3.5 (95% CI -5.5, -1.5) in 2015-16; -4.0 (95% CI -6.5, -1.6) in 2016-17) but not with other outcomes. SLIV was associated with lower MAARI per 1,000 in adults 65 + years (2014-15: -13.2, 95% CI -23.2, -3.2; 2015-16: -21.5, 95% CI -31.1, -11.9; 2016-17: -13.0, 95% CI -23.2, -2.9). There were few significant associations with other outcomes among adults.
Conclusions: A city-wide SLIV intervention was associated with higher influenza vaccination coverage, lower Oseltamivir prescriptions in school-aged children, and lower MAARI among people over 65 years, suggesting possible indirect effects of SLIV among older adults.

Keywords: Influenza; Influenza vaccination; School-located influenza vaccination.
 
Back
Top Bottom